CollabRx Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
16
- Latest Deal Type
-
M&A
- Financing Rounds
-
6
- Investments
-
2
CollabRx General Information
Description
Developer of data analytics software for the healthcare industry. The company utilizes cloud-based software intended to offer personalized cancer treatment planning services to cancer patients, thereby providing urine and blood toxicology and pain medication testing to physicians, clinics and rehabilitation facilities in the United States.
Contact Information
Website
www.collabrx.com(Operating Subsidiary)
Corporate Office
- 44 Montgomery Street
- Suite 800
- San Francisco, CA 94104
- United States
Corporate Office
- 44 Montgomery Street
- Suite 800
- San Francisco, CA 94104
- United States
CollabRx Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CollabRx Comparisons
Industry
Financing
Details
CollabRx Competitors (11)
One of CollabRx’s 11 competitors is Clario (Philadelphia), a Formerly PE-Backed company based in Philadelphia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Clario (Philadelphia) | Formerly PE-Backed | Philadelphia, PA | ||||
| Deep 6 AI | Formerly VC-backed | Pasadena, CA | ||||
| uMotif | Venture Capital-Backed | London, United Kingdom | ||||
| YPrime | Private Equity-Backed | Malvern, PA | ||||
| Medable | Venture Capital-Backed | Palo Alto, CA |
CollabRx Patents
CollabRx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2016195729-A2 | An actionability framework for genomic biomarker | Inactive | 03-Jun-2015 | ||
| US-20150347699-A1 | Actionability framework for genomic biomarker | Inactive | 03-Jun-2014 | ||
| WO-2012027716-A1 | Method to treat melanoma in braf inhibitor-resistant subjects | Inactive | 27-Aug-2010 | ||
| US-20110207323-A1 | Method of forming and patterning conformal insulation layer in vias and etched structures | Inactive | 25-Feb-2010 | ||
| EP-2366162-A1 | Individualized cancer treatment | Inactive | 18-Nov-2008 | G16B25/00 |
CollabRx Signals
CollabRx Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CollabRx Acquisitions (2)
CollabRx’s most recent deal was a Merger/Acquisition with Medytox Solutions. The deal was made on 28-Oct-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Medytox Solutions | 28-Oct-2015 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Tegal | 12-Jun-2012 | Merger/Acquisition | Application Specific Semiconductors |
CollabRx FAQs
-
When was CollabRx founded?
CollabRx was founded in 2008.
-
Where is CollabRx headquartered?
CollabRx is headquartered in San Francisco, CA.
-
What is the size of CollabRx?
CollabRx has 16 total employees.
-
What industry is CollabRx in?
CollabRx’s primary industry is Decision/Risk Analysis.
-
Is CollabRx a private or public company?
CollabRx is a Private company.
-
What is the current valuation of CollabRx?
The current valuation of CollabRx is .
-
What is CollabRx’s current revenue?
The current revenue for CollabRx is .
-
How much funding has CollabRx raised over time?
CollabRx has raised $11.8M.
-
Who are CollabRx’s investors?
CommerceNet and Tegal have invested in CollabRx.
-
Who are CollabRx’s competitors?
Clario (Philadelphia), Deep 6 AI, uMotif, YPrime, and Medable are some of the 11 competitors of CollabRx.
-
When was CollabRx acquired?
CollabRx was acquired on 02-Nov-2015.
-
Who acquired CollabRx?
CollabRx was acquired by Medytox Solutions.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process